Completed OBSERVATIONAL NCT01373125

Is the Neosquamous Epithelium Normal Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?

Sponsor: American Society for Gastrointestinal Endoscopy

Conditions Barrett's Esophagus Gastroesophageal Reflux Disease (GERD) Intestinal Metaplasia

Updated 10 times since 2017 Last updated: Sep 21, 2015 Started: Jun 30, 2011 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Barrett's Esophagus and Gastroesophageal Reflux Disease (GERD), this trial is completed. The trial is conducted by American Society for Gastrointestinal Endoscopy and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Society for Gastrointestinal Endoscopy
University of North Carolina, Chapel Hill

Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chapel Hill, United States